Evaluation report

Document	Type	Published
Disease-modifying therapies for Alzheimer’s disease	Evaluation report	September 2024
Teriparatide for treatment of osteoporosis in men aged over 50 years	Evaluation report	April 2024
Insulin aspart Sanofi (Trurapi): Biosimilar Insulin Aspart	Evaluation report	March 2022
Omalizumab and dupilumab for chronic rhinosinusitis with nasal polyps	Evaluation report	September 2021
Solriamfetol for obstructive sleep apnoea	Evaluation report	June 2021
Solriamfetol for narcolepsy	Evaluation report	May 2021
Doxylamine and pyridoxine (Xonvea) for the treatment of nausea and vomiting of pregnancy	Evaluation report	February 2019
ActiPatch for the management of localised musculoskeletal pain	Evaluation report	January 2019
Naloxone nasal spray for opioid overdose	Evaluation report	September 2018